Larimar Therapeutics (LRMR) Non Operating Income: 2014-2020
Historic Non Operating Income for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to $218,000.
- Larimar Therapeutics' Non Operating Income rose 32.12% to $218,000 in Q1 2020 from the same period last year, while for Mar 2020 it was $301,000, marking a year-over-year increase of 73.99%. This contributed to the annual value of $248,000 for FY2019, which is 200.81% up from last year.
- According to the latest figures from Q1 2020, Larimar Therapeutics' Non Operating Income is $218,000, which was up 626.67% from $30,000 recorded in Q4 2019.
- Larimar Therapeutics' Non Operating Income's 5-year high stood at $273,000 during Q4 2017, with a 5-year trough of -$254,000 in Q1 2018.
- For the 3-year period, Larimar Therapeutics' Non Operating Income averaged around $24,444, with its median value being $61,000 (2019).
- In the last 5 years, Larimar Therapeutics' Non Operating Income skyrocketed by 658.33% in 2017 and then plummeted by 213.76% in 2018.
- Over the past 5 years, Larimar Therapeutics' Non Operating Income (Quarterly) stood at $36,000 in 2016, then surged by 658.33% to $273,000 in 2017, then plummeted by 55.68% to $121,000 in 2018, then plummeted by 75.21% to $30,000 in 2019, then skyrocketed by 32.12% to $218,000 in 2020.
- Its Non Operating Income stands at $218,000 for Q1 2020, versus $30,000 for Q4 2019 and -$8,000 for Q3 2019.